Related Experiment Video
Updated: Jul 4, 2026
07:02
Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Contrast-induced nephropathy: the wheel has turned 360 degrees
H S Thomsen1, S K Morcos, B J Barrett
1Department of Diagnostic Radiology, Copenhagen University Hospital Herlev, Herlev, Denmark.
Acta Radiologica (Stockholm, Sweden : 1987)
|June 24, 2008
Summary
Contrast-induced nephropathy (CIN) increases patient morbidity and mortality, especially in those with chronic kidney disease (CKD) and diabetes. Current effective strategies involve minimizing contrast dose, hydration, and avoiding repeat injections.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication associated with increased morbidity and mortality.
- CIN is particularly prevalent in patients with advanced chronic kidney disease (CKD) and diabetes mellitus.
- Despite numerous publications, effective CIN prevention strategies remain contentious and evolving.
Purpose of the Study:
- To review and summarize current understanding and management strategies for contrast-induced nephropathy (CIN).
- To highlight the association of CIN with chronic kidney disease (CKD) and diabetes.
- To discuss the limited number of high-quality randomized controlled trials in CIN research.
Main Methods:
- Review of over 900 publications on CIN from the past five years.
- Analysis of the limited proportion (<5%) of randomized prospective controlled studies.
- Evaluation of proposed methods to diminish CIN incidence, including contrast choice, pharmacologic manipulation, and volume expansion.
Main Results:
- The pathophysiology of CIN remains uncertain, with renal blood flow reduction and tubular cell toxicity implicated.
- Despite extensive research, significant changes in CIN management have been minimal.
- Established approaches remain the most effective for reducing CIN risk.
Conclusions:
- The most effective current approach to reduce CIN risk includes using the smallest effective dose of low- or iso-osmolar contrast media.
- Volume expansion, cessation of nephrotoxic drugs, and avoiding repeat contrast injections within 48 hours are crucial.
- Further high-quality randomized controlled studies are needed to advance CIN prevention and management.
Related Concept Videos
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...